Advocating for drug development in newborn infants
Karel Allegaert1, Souvik Mitra2, Anne Smits3
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Hospital Pharmacy, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands.
Early Human Development
|November 2, 2024
Summary
Improving neonatal pharmacotherapy requires better drug information and advocacy. Structured approaches to evidence generation and trial design are crucial for advancing neonatal drug development and ensuring patient safety.
Area of Science:
- Neonatal pharmacology and drug development
- Clinical trial design and regulation
- Evidence-based medicine in pediatrics
Background:
- Neonatal care lacks comprehensive pharmacotherapy guidance, including formulation, dosage, safety, and efficacy data.
- Structured advocacy is essential to address these information gaps in neonatal medicine.
Purpose of the Study:
- To discuss advocacy strategies for enhancing medicinal information in neonatal care.
- To outline approaches for improving neonatal drug development through evidence generation and optimized trial design.
Main Methods:
- Review of current practices in neonatal drug information and clinical trials.
- Discussion of programmatic approaches to evidence generation (dosing, eligibility, outcomes).
- Consideration of trial designs (regulatory vs. informative) and supporting methodologies (real-world data, modeling).
Main Results:
- Advocacy can improve neonatal drug development by fostering evidence generation.
- Programmatic approaches and tailored trial designs are key to generating robust evidence.
- Real-world data, modeling, and extrapolation can support trial design.
Conclusions:
- Enhanced information and structured advocacy are vital for improving neonatal pharmacotherapy.
- Optimized trial design, incorporating Good Clinical Practice for neonates, is necessary for safe and effective drug development.
- Collaboration with Ethics Committees/IRBs and skilled research teams are critical for successful neonatal trials.
Related Concept Videos
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
01:26Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K